December 23, 2020 2:07 am Published by admin We are $167 away from reaching our goal to hire a Marketing / Public Relations expert to help us with broadcast media and social media getting the word out about Chondrosarcoma Awareness Day. The event will take place on February 6 in honor of Shayna’s birthday. We aim to do the following: 1. Educate the [...]
December 23, 2020 1:25 am Published by admin > > Snyder Family Holiday Letter 2020 > > > Merry Christmas and Happy Holidays from the Snyder family in Albuquerque, New Mexico! Like you and yours, we’ve had a year at Casa Del Snyder where the only constants has been the constant turmoil, upheaval, uncertainty and change. We’ve managed to make it through [...]
December 23, 2020 1:23 am Published by admin Agios to Sell Cancer Portfolio to Servier for $1.8 Billion By Emma Court December 21, 2020, 7:00 AM EST Updated on December 21, 2020, 10:18 AM EST Agios Pharmaceuticals Inc. said it agreed to sell its portfolio of oncology drugs to Servier Pharmaceuticals LLC for $1.8 billion in a move that will increase the biotechnology [...]
December 1, 2020 8:14 pm Published by admin On November 17, 2020 the Chondrosarcoma CS Foundation, Inc. held its first International Virtual Dialogue entitled: Straight Talk About Chondrosarcoma. There were 109 registrations and at one time we had over 80 participants attend the Virtual Dialogue consisting of CS Patients, Family members, Oncologists, Sarcoma Specialists, Radiation Oncologists, Pathologists, CS Clinical Researchers and others. “Straight [...]
November 26, 2020 8:09 pm Published by admin Hello fellow warriors….well some good news for all of us: I spoke today via video with a doc whose advice I get every 3 months when my CT scans are done, Jonathan Trent MD, Ph.D. (how’s that for qualified??) He runs a clinical trial for CS which has been going for years and gives me [...]
November 26, 2020 1:26 am Published by admin Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist Vivek Subbiah 1, Robert E Brown, Jamie Buryanek, Jonathan Trent, Avi Ashkenazi, Roy Herbst, Razelle Kurzrock PMID: 22914439 PMCID: PMC3496030 DOI: 10.1158/1535-7163.MCT-12-0358 Free PMC article Abstract Recombinant human Apo2L/TRAIL (dulanermin) is based on the ligand for death receptors [...]
November 26, 2020 1:14 am Published by admin New type of immunotherapy may pave the way for better cancer treatments by Karolinska Institutet From left: First author Silke Eisinger and last author Mikael Karlsson from Karolinska Institutet in Sweden. Credit: Mitch Eisinger Immunotherapy for cancer has made great advances and many patients can now receive effective treatments that were not available 10 years [...]
November 18, 2020 3:59 pm Published by admin Karina Galoian, Ph.D., is a research associate professor in the Department of Orthopaedics at the University of Miami Leonard M. Miller School of Medicine. She also leads the departmental Institutional Review Board and is Research Director of the Sarcoma Disease Site Group at Sylvester Comprehensive Cancer Center. For the past 10 years, Dr. Galoian has [...]
November 17, 2020 4:13 pm Published by admin Last Reminder. We go live at 7:15PM EST (New York time) tonight. We noticed that several of you have tested the connection and are ready to go. If you have any difficulties, Text me at 301-404-7100 We have 109 registrations. Looking forward to your participation. Chondrosarcoma Foundation is inviting you to a scheduled Zoom meeting. [...]
